Hepatology

Cover image for Vol. 63 Issue 2

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Michael H. Nathanson

Impact Factor: 11.055

ISI Journal Citation Reports © Ranking: 2014: 5/76 (Gastroenterology & Hepatology)

Online ISSN: 1527-3350

Associated Title(s): Clinical Liver Disease, Liver Transplantation

VIEW

  1. 1 - 100
  2. 101 - 146
  1. Clinical Observations in Hepatology

    1. Febuxostat-induced acute liver injury

      Matt Bohm, Raj Vuppalanchi, Naga Chalasani and The Drug-Induced Liver Injury Network (DILIN)

      Article first published online: 3 FEB 2016 | DOI: 10.1002/hep.28403

  2. Liver Failure, Cirrhosis and Portal Hypertension

    1. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study

      Marta Cavallin, Salvatore Piano, Antonietta Romano, Silvano Fasolato, Anna Chiara Frigo, Gianpiero Benetti, Elisabetta Gola, Filippo Morando, Marialuisa Stanco, Silvia Rosi, Antonietta Sticca, Umberto Cillo and Paolo Angeli

      Article first published online: 3 FEB 2016 | DOI: 10.1002/hep.28396

  3. Hepatobiliary Malignancies

    1. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21Waf/Cip1 stabilization by activating the ERK1/2-MAPK pathway

      Yonglong Zhang, Yanfeng Liu, Jinlin Duan, Haibo Yan, Jun Zhang, Huilu Zhang, Qi Fan, Feifei Luo, Guoquan Yan, Ke Qiao and Jie Liu

      Article first published online: 3 FEB 2016 | DOI: 10.1002/hep.28395

    2. Systemic genome screening identified the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma

      Chuan-chuan Zhou, Fu Yang, Sheng-xian Yuan, Jin-zhao Ma, Feng Liu, Ji-hang Yuan, Feng-rui Bi, Kong-ying Lin, Jian-hua Yin, Guang-wen Cao, Wei-ping Zhou, Fang Wang and Shu-han Sun

      Article first published online: 3 FEB 2016 | DOI: 10.1002/hep.28393

  4. Viral Hepatitis

    1. Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15-year follow-up

      Philip R. Spradling, Lisa R. Bulkow, Susan E. Negus, Chriss Homan, Michael G. Bruce and Brian J. McMahon

      Article first published online: 1 FEB 2016 | DOI: 10.1002/hep.28375

  5. Liver Capsule

    1. Liver capsule: Cholangiocarcinoma (CCA)

      Sumera Rizvi and Gregory J. Gores

      Article first published online: 1 FEB 2016 | DOI: 10.1002/hep.28401

  6. Hepatobiliary Malignancies

    1. You have full text access to this OnlineOpen article
      Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition

      Shuai Xiao, Rui-Min Chang, Ming-Yang Yang, Xiong Lei, Xiao Liu, Wen-Bin Gao, Jing-Lei Xiao and Lian-Yue Yang

      Article first published online: 26 JAN 2016 | DOI: 10.1002/hep.28417

  7. Steatohepatitis and Metabolic Liver Disease

    1. You have full text access to this OnlineOpen article
      Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants

      Giancarlo Chesi, Ramanath N. Hegde, Simona Iacobacci, Mafalda Concilli, Seetharaman Parashuraman, Beatrice Paola Festa, Elena V. Polishchuk, Giuseppe Di Tullio, Annamaria Carissimo, Sandro Montefusco, Diana Canetti, Maria Monti, Angela Amoresano, Piero Pucci, Bart van de Sluis, Svetlana Lutsenko, Alberto Luini and Roman S. Polishchuk

      Article first published online: 25 JAN 2016 | DOI: 10.1002/hep.28398

  8. Viral Hepatitis

    1. You have full text access to this OnlineOpen article
      Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans

      Christabel Kelly, Leo Swadling, Stefania Capone, Anthony Brown, Rachel Richardson, John Halliday, Annette von Delft, Ye Oo, David Mutimer, Ayako Kurioka, Felicity Hartnell, Jane Collier, Virginia Ammendola, Mariarosaria Del Sorbo, Fabiana Grazioli, Maria Luisa Esposito, Stefania Di Marco, Loredana Siani, Cinzia Traboni, Adrian V.S. Hill, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Antonella Folgori, Paul Klenerman and Eleanor Barnes

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28294

  9. Steatohepatitis and Metabolic Liver Disease

    1. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population

      Aynur Unalp-Arida and Constance E. Ruhl

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28390

    2. A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism

      Xi Lan, Jidong Yan, Juan Ren, Bo Zhong, Jing Li, Yue Li, Li Liu, Jing Yi, Qingzhu Sun, Xudong Yang, Jian Sun, Liesu Meng, Wenhua Zhu, Rikard Holmdahl, Dongmin Li and Shemin Lu

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28391

  10. Reviews

    1. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

      Giulio Marchesini, Salvatore Petta and Riccardo Dalle Grave

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28392

  11. Steatohepatitis and Metabolic Liver Disease

    1. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

      Christophe Cassinotto, Jérome Boursier, Victor de Lédinghen, Jérome Lebigot, Bruno Lapuyade, Paul Cales, Jean-Baptiste Hiriart, Sophie Michalak, Brigitte Le Bail, Victoire Cartier, Amaury Mouries, Frédéric Oberti, Isabelle Fouchard-Hubert, Julien Vergniol and Christophe Aubé

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28394

  12. Hepatobiliary Malignancies

    1. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma

      Han-Yue OuYang, Jing Xu, Jun Luo, Ru-Hai Zou, Keng Chen, Yong Le, Yong-Fa Zhang, Wei Wei, Rong-Ping Guo and Ming Shi

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28397

  13. Correspondence

    1. B-cell depletion in autoimmune hepatitis: Is it safe for the bowel?

      Mostafa M. Sira and Ahmad M. Sira

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28405

  14. Liver Injury and Regeneration

    1. Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice

      Kunimaro Furuta, Yuichi Yoshida, Satoshi Ogura, Tomohide Kurahashi, Takashi Kizu, Shinichiro Maeda, Mayumi Egawa, Norihiro Chatani, Keigo Nishida, Yoshikazu Nakaoka, Shinichi Kiso, Yoshihiro Kamada and Tetsuo Takehara

      Article first published online: 22 JAN 2016 | DOI: 10.1002/hep.28410

  15. Steatohepatitis and Metabolic Liver Disease

    1. NKp46+ natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice

      Annie-Carole Tosello-Trampont, Peter Krueger, Sowmya Narayanan, Susan G. Landes, Norbert Leitinger and Young S. Hahn

      Article first published online: 21 JAN 2016 | DOI: 10.1002/hep.28389

  16. Hepatology Elsewhere

    1. Dual Notch signaling in proinflammatory macrophage activation

      Hyuk Soo Eun and Won-Il Jeong

      Article first published online: 21 JAN 2016 | DOI: 10.1002/hep.28386

  17. Viral Hepatitis

    1. Retinoid regulation of antiviral innate immunity in hepatocytes

      Noell E. Cho, Bo-Ram Bang, Purnima Gurung, Meng Li, Dahn L. Clemens, T. Michael Underhill, Laura P. James, Jenifer R. Chase and Takeshi Saito

      Article first published online: 21 JAN 2016 | DOI: 10.1002/hep.28380

  18. Liver Biology and Pathobiology

    1. Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice

      Denada Dibra, Xueqing Xia, Abhisek Mitra, Jeffry J. Cutrera, Guillermina Lozano and Shulin Li

      Article first published online: 21 JAN 2016 | DOI: 10.1002/hep.28379

  19. Viral Hepatitis

    1. Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women

      Mark H. Kuniholm, Edgar Ong, Boris M. Hogema, Marco Koppelman, Kathryn Anastos, Marion G. Peters, Eric C. Seaberg, Yue Chen, Kenrad E. Nelson and Jeffrey M. Linnen

      Article first published online: 16 JAN 2016 | DOI: 10.1002/hep.28384

  20. Autoimmune, Cholestatic and Biliary Disease

    1. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis

      Luigi Locatelli, Massimiliano Cadamuro, Carlo Spirlì, Romina Fiorotto, Silvia Lecchi, Carola Maria Morell, Yury Popov, Roberto Scirpo, Maria De Matteis, Mariangela Amenduni, Andrea Pietrobattista, Giuliano Torre, Detlef Schuppan, Luca Fabris and Mario Strazzabosco

      Article first published online: 16 JAN 2016 | DOI: 10.1002/hep.28382

  21. Editorial

  22. Hepatology Elsewhere

  23. Viral Hepatitis

    1. Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study

      Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Shang-Ju Wu, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen and Jia-Horng Kao

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28387

  24. Editorial

    1. Predicting risk in primary biliary cholangitis

      Bertus Eksteen

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28377

  25. Steatohepatitis and Metabolic Liver Disease

    1. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)

      Yong-ho Lee, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha and Kwang-Hyub Han

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28376

    2. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease

      Jake P. Mann, Rita De Vito, Antonella Mosca, Anna Alisi, Matthew J. Armstrong, Massimiliano Raponi, Ulrich Baumann and Valerio Nobili

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28374

  26. Autoimmune, Cholestatic and Biliary Disease

    1. You have full text access to this OnlineOpen article
      Cholestasis-induced adaptive remodeling of interlobular bile ducts

      Nachiket Vartak, Amruta Damle-Vartak, Beate Richter, Olaf Dirsch, Uta Dahmen, Seddik Hammad and Jan G. Hengstler

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28373

  27. Liver Biology and Pathobiology

    1. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis

      Hui Guo, Li Jing, Yangzi Cheng, Vassilis Atsaves, Yi Lv, Tao Wu, Rujuan Su, Yamin Zhang, Ronghua Zhang, Wenbin Liu, George Z. Rassidakis, Yongchang Wei, Kejun Nan and Francois X. Claret

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28372

  28. Correspondence

    1. Reply

      Annabel Blasi, Virginia Hernandez-Gea, Juan Carlos Reverter and Juan Carlos Garcia-Pagán

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28371

  29. Steatohepatitis and Metabolic Liver Disease

    1. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage

      Benedetta Donati, Benedetta Maria Motta, Piero Pingitore, Marica Meroni, Alessandro Pietrelli, Anna Alisi, Salvatore Petta, Chao Xing, Paola Dongiovanni, Benedetta del Menico, Raffaela Rametta, Rosellina Margherita Mancina, Sara Badiali, Anna Ludovica Fracanzani, Antonio Craxì, Silvia Fargion, Valerio Nobili, Stefano Romeo and Luca Valenti

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28370

  30. Hepatobiliary Malignancies

    1. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

      Fabio Piscaglia, Gianluca Svegliati-Baroni, Andrea Barchetti, Anna Pecorelli, Sara Marinelli, Claudio Tiribelli, Stefano Bellentani and on behalf of the HCC-NAFLD Italian Study Group

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28368

    2. You have full text access to this OnlineOpen article
      Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis

      Kwang Hwa Jung, Jing Zhang, Chong Zhou, Hong Shen, Mihai Gagea, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Anil K. Sood and Laura Beretta

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28367

  31. Editorial

  32. Comments from the Editors

    1. Stemness and reprogramming in liver cancer

      Snorri S. Thorgeirsson

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28362

  33. Liver Failure, Cirrhosis and Portal Hypertension

    1. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial

      Àngels Escorsell, Oana Pavel, Andrés Cárdenas, Rosa Morillas, Elba Llop, Càndid Villanueva, Juan C. Garcia-Pagán, Jaime Bosch and ; for the Variceal Bleeding Study Group

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28360

    2. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

      Gideon M. Hirschfield, M. Eric Gershwin, Richard Strauss, Marlyn J. Mayo, Cynthia Levy, Bin Zou, Jewel Johanns, Ivo P. Nnane, Bidisha Dasgupta, Katherine Li, Carlo Selmi, Hanns-Ulrich Marschall, David Jones, Keith Lindor and ; for the PURIFI Study Group

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28359

  34. Hepatobiliary Malignancies

    1. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells

      Jana Samarin, Vibor Laketa, Mona Malz, Stephanie Roessler, Ilan Stein, Elad Horwitz, Stephan Singer, Eleni Dimou, Antonio Cigliano, Michaela Bissinger, Christine Susanne Falk, Xin Chen, Steven Dooley, Eli Pikarsky, Diego Francesco Calvisi, Carsten Schultz, Peter Schirmacher and Kai Breuhahn

      Article first published online: 14 JAN 2016 | DOI: 10.1002/hep.28357

  35. Steatohepatitis and Metabolic Liver Disease

    1. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

      Jérôme Boursier, Olaf Mueller, Matthieu Barret, Mariana Machado, Lionel Fizanne, Felix Araujo-Perez, Cynthia D. Guy, Patrick C. Seed, John F. Rawls, Lawrence A. David, Gilles Hunault, Frédéric Oberti, Paul Calès and Anna Mae Diehl

      Article first published online: 13 JAN 2016 | DOI: 10.1002/hep.28356

  36. Hepatobiliary Malignancies

    1. Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection

      Joana Ferrer-Fàbrega, Alejandro Forner, Alexandre Liccioni, Rosa Miquel, Víctor Molina, Miquel Navasa, Constantino Fondevila, Juan Carlos García-Valdecasas, Jordi Bruix and Josep Fuster

      Article first published online: 13 JAN 2016 | DOI: 10.1002/hep.28339

  37. Correspondence

    1. Quality of anticoagulation and outcome of bleeding in cirrhosis

      Xingshun Qi, Valerio De Stefano and Xiaozhong Guo

      Article first published online: 12 JAN 2016 | DOI: 10.1002/hep.28369

  38. Editorial

    1. Pandora's box opens for cholestatic liver disease

      Peter L.M. Jansen and Frank G. Schaap

      Article first published online: 12 JAN 2016 | DOI: 10.1002/hep.28364

    2. Concomitant drug-induced liver and skin reactions: An Indian experience

      Einar S. Björnsson and Jon Hjaltalin Ólafsson

      Article first published online: 12 JAN 2016 | DOI: 10.1002/hep.28361

  39. Liver Failure, Cirrhosis and Portal Hypertension

    1. Antibiotic prophylaxis in cirrhosis: Good and bad

      Javier Fernández, Puneeta Tandon, Jose Mensa and Guadalupe Garcia-Tsao

      Article first published online: 11 JAN 2016 | DOI: 10.1002/hep.28330

  40. Correspondence

  41. Editorial

  42. Correspondence

    1. Reply

      Lesley De Pietri, Marcello Bianchini, Guadalupe Garcia-Tsao and Erica Villa

      Article first published online: 8 JAN 2016 | DOI: 10.1002/hep.28335

    2. Association between systemic inflammatory response syndrome and mortality in alcoholic hepatitis: A meta-analysis

      Veeravich Jaruvongvanich, Sikarin Upala and Anawin Sanguankeo

      Article first published online: 6 JAN 2016 | DOI: 10.1002/hep.28366

    3. Reply

      Chong-Gee Teo, Ajay Yesupriya, Man-Huei Chang and Lyna Zhang

      Article first published online: 6 JAN 2016 | DOI: 10.1002/hep.28358

  43. Liver Injury and Regeneration

    1. The neuroimmune guidance cue netrin-1 controls resolution programs and promotes liver regeneration

      Martin Schlegel, David Köhler, Andreas Körner, Tiago Granja, Andreas Straub, Martin Giera and Valbona Mirakaj

      Article first published online: 6 JAN 2016 | DOI: 10.1002/hep.28347

  44. Correspondence

    1. Apolipoprotein E ε3 and ε4 are associated with a lower exposure to hepatitis E virus in American non-Hispanic blacks

      Sven Pischke, Johannes Hartl, Anne-Marie Roque-Afonso and Vincent Mallet

      Article first published online: 5 JAN 2016 | DOI: 10.1002/hep.28355

  45. Liver Failure, Cirrhosis and Portal Hypertension

  46. Comments from the Editors

    1. We are not in kansas anymore: The unfamiliar landscape of NASH

      Wajahat Z. Mehal

      Article first published online: 5 JAN 2016 | DOI: 10.1002/hep.28348

  47. Correspondence

  48. Liver Failure, Cirrhosis and Portal Hypertension

    1. An empirical broad spectrum antibiotic therapy in health-care–associated infections improves survival in patients with cirrhosis: A randomized trial

      Manuela Merli, Cristina Lucidi, Vincenza Di Gregorio, Barbara Lattanzi, Valerio Giannelli, Michela Giusto, Alessio Farcomeni, Giancarlo Ceccarelli, Marco Falcone, Oliviero Riggio and Mario Venditti

      Article first published online: 5 JAN 2016 | DOI: 10.1002/hep.28332

  49. Liver Capsule

    1. Liver capsule: Hepatitis C virus host cell entry

      Sharon E. Hopcraft and Matthew J. Evans

      Article first published online: 4 JAN 2016 | DOI: 10.1002/hep.28329

  50. Editorial

    1. Mixed lineage kinase 3 connects hepatocellular lipotoxicity with macrophage chemotaxis

      Jan-Peter Sowa, Christian Dominik Fingas and Ali Canbay

      Article first published online: 4 JAN 2016 | DOI: 10.1002/hep.28333

  51. Autoimmune, Cholestatic and Biliary Disease

    1. You have full text access to this OnlineOpen article
      Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum

      Shadi Abu-Hayyeh, Caroline Ovadia, TinaMarie Lieu, Dane D. Jensen, Jenny Chambers, Peter H. Dixon, Anita Lövgren-Sandblom, Ruth Bolier, Dagmar Tolenaars, Andreas E. Kremer, Argyro Syngelaki, Muna Noori, David Williams, Jose J.G. Marin, Maria J. Monte, Kypros H. Nicolaides, Ulrich Beuers, Ronald Oude-Elferink, Paul T. Seed, Lucy Chappell, Hanns-Ulrich Marschall, Nigel W. Bunnett and Catherine Williamson

      Article first published online: 28 DEC 2015 | DOI: 10.1002/hep.28265

  52. Liver Injury and Regeneration

    1. The profile of platelet α-granule released molecules affects postoperative liver regeneration

      Patrick Starlinger, Stefanie Haegele, Florian Offensperger, Lukas Oehlberger, David Pereyra, Julia B Kral, Waltraud C. Schrottmaier, Sigrun Badrnya, Thomas Reiberger, Arnulf Ferlitsch, Judith Stift, Florian Luf, Christine Brostjan, Thomas Gruenberger and Alice Assinger

      Article first published online: 28 DEC 2015 | DOI: 10.1002/hep.28331

  53. Concise Review

  54. Correspondence

    1. Clinical characteristics and outcomes of pyogenic vertebral osteomyelitis in patients with cirrhosis

      Seong Yeon Park, Ki-Ho Park, Oh-Hyun Cho, Yu-Mi Lee, Sang-Ho Choi and Mi Suk Lee

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28319

  55. Hepatology Elsewhere

    1. Hepatocytes come out of left field

      Malcolm R. Alison and Wey-Ran Lin

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28315

  56. Correspondence

    1. Reply

      Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stal, Stergios Kechagias and Rolf Hultcrantz

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28314

  57. Viral Hepatitis

    1. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection

      Lin Fan, Kwame Owusu-Edusei Jr., Sarah F. Schillie and Trudy V. Murphy

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28310

  58. Autoimmune, Cholestatic and Biliary Disease

    1. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3

      Jean-Louis Delaunay, Anne-Marie Durand-Schneider, Claire Dossier, Thomas Falguières, Julien Gautherot, Anne Davit-Spraul, Tounsia Aït-Slimane, Chantal Housset, Emmanuel Jacquemin and Michèle Maurice

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28300

  59. Hepatology Elsewhere

    1. Continued controversy over the safety of beta-blockers in decompensated cirrhosis

      Agustín Albillos, Javier Martínez and Luis Téllez

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28293

  60. Special Articles

    1. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process

      Cyriel Y. Ponsioen, Roger W. Chapman, Olivier Chazouillères, Gideon M. Hirschfield, Tom H. Karlsen, Ansgar W. Lohse, Massimo Pinzani, Erik Schrumpf, Michael Trauner and Gregory J. Gores

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28256

  61. Correspondence

    1. Reply

      Salvatore Petta and Antonio Craxì

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.27949

    2. Reply

      Koji Miyanishi, Masayoshi Kobune and Junji Kato

      Article first published online: 23 DEC 2015 | DOI: 10.1002/hep.28290

    3. Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndrome

      Abhinav Vasudevan, Zaid Ardalan, Paul Gow, Peter Angus and Adam Testro

      Article first published online: 22 DEC 2015 | DOI: 10.1002/hep.28325

    4. Reply

      Marta Cavallin, Salvatore Piano and Paolo Angeli

      Article first published online: 22 DEC 2015 | DOI: 10.1002/hep.28324

  62. Viral Hepatitis

    1. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral

      Benoit Callendret, Heather B. Eccleston, William Satterfield, Stefania Capone, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia and Christopher M. Walker

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28309

  63. Liver Injury and Regeneration

    1. Akt-mediated foxo1 inhibition is required for liver regeneration

      Montse Pauta, Noemi Rotllan, Ana Fernández-Hernando, Cedric Langhi, Jordi Ribera, Mingjian Lu, Loreto Boix, Jordi Bruix, Wladimiro Jimenez, Yajaira Suárez, David A. Ford, Angel Baldán, Morris J. Birnbaum, Manuel Morales-Ruiz and Carlos Fernández-Hernando

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28286

  64. Correspondence

    1. Reply

      Christine E. McLaren, James C. Barton, Pradyumna D. Phatak, Mary J. Emond, V. Nathan Subramaniam, Lyle C. Gurrin, Paul C. Adams, Lawrie W. Powell, Grant A. Ramm, Gregory J. Anderson and Gordon D. McLaren

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28260

  65. Steatohepatitis and Metabolic Liver Disease

    1. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease

      Hyunjoo Kwon, Kyoungsub Song, Chang Han, Weina Chen, Ying Wang, Srikanta Dash, Kyu Lim and Tong Wu

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28289

  66. Correspondence

    1. Recombinant hepatitis C viruses that might hamper accurate genotype classification and choice of treatment with direct-acting agents, southeastern France

      Philippe Colson, Patrick Borentain, Catherine Dhiver, Serge Benhaim, René Gerolami and Catherine Tamalet

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28261

    2. B cells in autoimmune hepatitis: Friend or foe?

      Jin-Zhong Dong, Li-Ping Wang and Jian-Hua Zhu

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28298

  67. Viral Hepatitis

    1. Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

      Anthony Cousien, Viet Chi Tran, Sylvie Deuffic-Burban, Marie Jauffret-Roustide, Jean-Stéphane Dhersin and Yazdan Yazdanpanah

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28227

  68. Correspondence

    1. Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity

      Anne T. Schneider, Jérémie Gautheron, Frank Tacke, Mihael Vucur and Tom Luedde

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28225

  69. Reviews

    1. Physical activity and liver diseases

      Annalisa Berzigotti, Uttara Saran and Jean-François Dufour

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28132

  70. Hepatobiliary Malignancies

    1. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus–related hepatocellular carcinoma after radiofrequency ablation

      Teng-Yu Lee, Jaw-Town Lin, Yi-Siou Zeng, Yi-Ju Chen, Ming-Shiang Wu and Chun-Ying Wu

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28266

  71. Correspondence

    1. Iron absorption in nonalcoholic steatohepatitis and dysmetabolic iron overload syndrome

      Marc Ruivard, Fabrice Laine and Yves Deugnier

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28296

    2. Reply

      Kathie Beland and Fernando Alvarez

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28299

    3. Reply

      Vincent Wai-Sun Wong, Grace Lai-Hung Wong and Henry Lik-Yuen Chan

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28305

  72. Steatohepatitis and Metabolic Liver Disease

    1. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study

      Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Judy Ching-Lam Yeung, Chloe Yuk-Kiu Fung, Jasmine Ka-Lei Chan, Zoe Hoi-Yi Chang, Chelsia Tsz-Yan Kwan, Hiu-Wan Lam, Jenny Limquiaco, Angel Mei-Ling Chim, Cheuk-Man Yu and Henry Lik-Yuen Chan

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28253

  73. Correspondence

    1. The end of RIPK1-RIPK3-MLKL–mediated necroptosis in acetaminophen-induced hepatotoxicity?

      Xiao Yang, Xiaojuan Chao, Zheng-Tao Wang and Wen-Xing Ding

      Article first published online: 18 DEC 2015 | DOI: 10.1002/hep.28263

  74. Steatohepatitis and Metabolic Liver Disease

    1. You have full text access to this OnlineOpen article
      Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice

      Karim Gariani, Keir J. Menzies, Dongryeol Ryu, Casey J. Wegner, Xu Wang, Eduardo R. Ropelle, Norman Moullan, Hongbo Zhang, Alessia Perino, Vera Lemos, Bohkyung Kim, Young-Ki Park, Alessandra Piersigilli, Tho X. Pham, Yue Yang, Chai Siah Ku, Sung I. Koo, Anna Fomitchova, Carlos Cantó, Kristina Schoonjans, Anthony A. Sauve, Ji-Young Lee and Johan Auwerx

      Article first published online: 16 DEC 2015 | DOI: 10.1002/hep.28245

  75. Correspondence

    1. Selection criteria for resection in hepatocellular carcinoma: Can we expand them?

      Simona Onali, Francesco Figorilli and James O'Beirne

      Article first published online: 16 DEC 2015 | DOI: 10.1002/hep.28141

  76. Steatohepatitis and Metabolic Liver Disease

    1. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

      Samar H. Ibrahim, Petra Hirsova, Kyoko Tomita, Steven F. Bronk, Nathan W. Werneburg, Stephen A. Harrison, Val S. Goodfellow, Harmeet Malhi and Gregory J. Gores

      Article first published online: 11 DEC 2015 | DOI: 10.1002/hep.28252

  77. Correspondence

    1. Hypomethylation and hypohydroxymethylation of DNA in hepatocellular carcinoma and cholangiocarcinoma

      Zhi Li, Jiexiong Feng and Xiaoyi Sun

      Article first published online: 30 NOV 2015 | DOI: 10.1002/hep.28272

  78. Autoimmune, Cholestatic and Biliary Disease

    1. You have full text access to this OnlineOpen article
      Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice

      Mei Zhou, R. Marc Learned, Stephen J. Rossi, Alex M. DePaoli, Hui Tian and Lei Ling

      Article first published online: 30 NOV 2015 | DOI: 10.1002/hep.28257

  79. Correspondence

    1. Reply

      Kai Markus Schneider, Veerle Bieghs, Oliver Pabst and Christian Trautwein

      Article first published online: 27 NOV 2015 | DOI: 10.1002/hep.28145

    2. Reply

      Silvia Udali, Sara Moruzzi, Andrea Ruzzenente, Sang-Woon Choi and Simonetta Friso

      Article first published online: 26 NOV 2015 | DOI: 10.1002/hep.28271

  80. Liver Injury and Regeneration

    1. Drug-induced liver injury associated with stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases

      Harshad Devarbhavi, Sujata Raj, Venu H. Aradya, Vijaykumar T. Rangegowda, Girish P. Veeranna, Rajvir Singh, Vishnuvardan Reddy and Mallikarjun Patil

      Article first published online: 26 NOV 2015 | DOI: 10.1002/hep.28270

  81. Correspondence

    1. Critical roles of CX3CR1+ mononuclear phagocytes in maintaining gut-liver axis health

      Zongxin Ling, Yiwen Cheng and Lanjuan Li

      Article first published online: 26 NOV 2015 | DOI: 10.1002/hep.28147

VIEW

  1. 1 - 100
  2. 101 - 146

SEARCH

SEARCH BY CITATION